Results 91 to 100 of about 1,164,954 (301)

Poor Performance Among Trainees in a Dutch Postgraduate GP Training Program

open access: yes, 2016
BACKGROUND AND OBJECTIVES: Poor performance among trainees is an important issue, for patient safety and economic reasons. While early identification might enhance remediation measures, we explored the frequency, nature, and risk factors of poor ...
de Groot, Esther   +6 more
core  

Forces influencing poor performance of Serbian food industry [PDF]

open access: yesIndustrija, 2018
The main objective of this paper is to consider the factors that led to the poor performances of the Serbian agribusiness sector in recent years. Moreover, specific objectives are to discuss the productivity trends in agribusiness sector, to evaluate ...
Nikolić Ivan, Brankov Tatjana
doaj  

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

open access: yesMolecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel   +12 more
wiley   +1 more source

Poor Performance of Random Random Number Generation

open access: yes, 2007
Knuth [Knu98] shows that iterations a random function perform poorly on average as a random number generator and proposes a generalization in which the next value depends on two or more previous values. This note demonstrates the equally poor performance
Robin Pemantle
core  

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Is poor performance of UK unit trusts explained by recession bias [PDF]

open access: yes, 2014
This study investigates the performance of UK Unit Trusts to examine the effect of fund managers’ stock picking ability (selectivity) or ability to time the market (timing).
Ntozi-Obwale, Patricia
core  

Poor scholastic performance in children and adolescents

open access: yesIndian Pediatrics, 2011
Scholastic achievement has become an index of child’s future in this highly competitive world.Unrecognized and unresolved, scholastic backwardness has a lifelong impact on the child and adolescent, affecting school completion, higher education, interpersonal relationships, prospects foremployment, marriage etc.
openaire   +2 more sources

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy